A Consultant's Perspective on the Regulatory Hurdles to Adaptive Trials
暂无分享,去创建一个
[1] Cyrus R Mehta,et al. Adaptive, group sequential and decision theoretic approaches to sample size determination , 2006, Statistics in medicine.
[2] Robert T O'Neill,et al. A Regulatory View on Adaptive/Flexible Clinical Trial Design , 2006, Biometrical journal. Biometrische Zeitschrift.
[3] A. Koch. Confirmatory Clinical Trials with an Adaptive Design , 2006, Biometrical journal. Biometrische Zeitschrift.
[4] W. Brannath,et al. Recursive Combination Tests , 2002 .
[5] Anastasios A. Tsiatis,et al. Flexible Sample Size Considerations Using Information-Based Interim Monitoring , 2001 .
[6] H. Schäfer,et al. Adaptive Group Sequential Designs for Clinical Trials: Combining the Advantages of Adaptive and of Classical Group Sequential Approaches , 2001, Biometrics.
[7] KyungMann Kim. Group Sequential Methods with Applications to Clinical Trials , 2001 .
[8] P Bauer,et al. Interim Analysis and Sample Size Reassessment , 2000, Biometrics.
[9] T. Friede,et al. Re-calculating the sample size in internal pilot study designs with control of the type I error rate. , 2000, Statistics in medicine.
[10] W. Lehmacher,et al. Adaptive Sample Size Calculations in Group Sequential Trials , 1999, Biometrics.
[11] M Kieser,et al. Combining different phases in the development of medical treatments within a single trial. , 1999, Statistics in medicine.
[12] D O Scharfstein,et al. The use of simulation and bootstrap in information-based group sequential studies. , 1998, Statistics in medicine.
[13] P. Bauer,et al. Evaluation of experiments with adaptive interim analyses. , 1994, Biometrics.
[14] A A Tsiatis,et al. Exact confidence intervals following a group sequential test. , 1984, Biometrics.